BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8934774)

  • 1. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
    Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
    Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
    Zhou G; Lin D; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCNA--a cell proliferation marker in vocal chord cancer. Part I: Premalignant laryngeal lesions.
    Pignataro LD; Broich G; Lavezzi AM; Biondo B; Ottaviani F
    Anticancer Res; 1995; 15(4):1517-20. PubMed ID: 7654040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, morphological and immunohistochemical aspects in laryngeal premalignant lesions.
    Anghelina F; Ioniţă E; Popescu CF; Ioniţă I; Mogoantă C; Ciolofan S; Mogoantă L
    Rom J Morphol Embryol; 2006; 47(2):169-74. PubMed ID: 17106526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
    Broich G; Lavezzi AM; Biondo B; Pignataro LD
    In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hMSH2 mismatch repair protein expression in dysplasia, carcinoma in situ and invasive squamous cell carcinoma of the vocal folds.
    Hussein MR; Aref EE; Yassen DG; Ramadan MO
    Cancer Invest; 2009 Jan; 27(1):38-46. PubMed ID: 19160096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
    Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
    Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The meaning of the expression of PCNA and c-erbB-2 in the hyperplasia of laryngeal epithelium].
    Yao Q; Lu X; Huang Z; Cao Y; Jiang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):263-4. PubMed ID: 12563981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
    Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
    Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Precancerous states of the larynx: analysis of mono- and polyclonality of the cells with high proliferative index (p53, PCNA)].
    Gabriel A; Namysłowski G; Drozdzowska B; Morawski K; Steplewska-Mazur K; Gwóźdź M
    Otolaryngol Pol; 2000; 54 Suppl 31():178-81. PubMed ID: 10974878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M; Domagała W
    Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of proliferating cell nuclear antigen (PCNA) in dysplasia of the bronchial epithelium.
    Pendleton N; Dixon GR; Burnett HE; Occleston NL; Myskow MW; Green JA
    J Pathol; 1993 Jun; 170(2):169-72. PubMed ID: 8102179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
    Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
    Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
    Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
    Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of vocal cord polyps applying markers of squamous cell carcinogenesis.
    Braut T; Krstulja M; Marijić B; Maržić D; Kujundžić M; Brumini G; Vučinić D; Oštarijaš E
    Pathol Res Pract; 2019 Jan; 215(1):144-150. PubMed ID: 30455127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive elimination of precancerous lesions of the vocal cords to avoid risk of cancer.
    Rohde M; Grøntved ÅM; Krogdahl A; Godballe C
    Dan Med J; 2012 May; 59(5):A4399. PubMed ID: 22549484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.